In this issue:
Characteristics, management and outcomes in congestive HF
Dapagliflozin and mode of death in HF with improved EF
Changes in walking speed and handgrip strength after HF hospitalisation
Vericiguat vs. sacubitril-valsartan for HFREF
Sex disparities in guideline-directed medical therapy for HF
Association of β-blocker use with exercise capacity in HFPEF
Sacubitril-valsartan in hospitalised decompensated HF
BP, hypertension and HF risk
Prevalence of subclinical AF in HFPEF
Treatment effect of intravenous iron in iron-deficient HF
Please login below to download this issue (PDF)